PRESS RELEASE published on 11/03/2023 at 18:05, 2 years 11 months ago Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1
PRESS RELEASE published on 10/25/2023 at 15:00, 2 years 11 months ago Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 11 months ago Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society
PRESS RELEASE published on 07/06/2023 at 14:00, 3 years 3 months ago Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases
PRESS RELEASE published on 06/05/2023 at 14:00, 3 years 4 months ago Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi
PRESS RELEASE published on 03/27/2023 at 16:04, 3 years 6 months ago Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases
Published on 10/07/2026 at 08:00, 22 minutes ago VEON and Amdocs Enter 10-Year Strategic Agreement to Advance Digital Services powered by Amdocs' AI technology
Published on 10/07/2026 at 01:45, 6 hours 37 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 6 hours 52 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 7 hours 17 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 8 hours 37 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/07/2026 at 08:05, 16 minutes ago OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
Published on 10/07/2026 at 08:05, 16 minutes ago Market Logic's DeepSights MCP scales market insights reach and business impact through enterprise-wide AI workflows
Published on 10/07/2026 at 08:00, 22 minutes ago New sports cars, greater exclusivity, stronger profitability: Porsche presents new strategy through to 2035
Published on 10/07/2026 at 07:30, 52 minutes ago Nordex Group records 389 MW of new orders in Türkiye
Published on 10/07/2026 at 08:15, 7 minutes ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
Published on 10/07/2026 at 08:00, 22 minutes ago Neoen launches construction of its 346 MW Goyder North Wind Farm in South Australia
Published on 10/06/2026 at 19:15, 13 hours 7 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 18:39, 13 hours 42 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 14 hours 7 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
